BIOMIMETIC THERAPEUTICS, INC. — Form D
BIOMIMETIC THERAPEUTICS, INC. of Franklin, TN, a company, filed a Form D exempt-offering notice with the SEC on 2009-04-21. The offering totals $8.0M, of which $8.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2009-04-21
- Form: D
- Accession: 0001144204-09-021514
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $8.0M
- Amount sold: $8.0M
- Investors: 1
- Date of first sale: 2009-04-07
- Security types: equity
- Revenue range: $1,000,001 - $5,000,000
- SEC file number: 021-55779
Issuer
- Name: BIOMIMETIC THERAPEUTICS, INC.
- CIK: 0001138400
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 389 Nichol Mill Lane, Franklin, TN, 37067
- Phone: (615)844-1280
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Chris Ehrlich | Director | South San Francisco, CA |
| James Murphy | Director | Chicago, IL |
| Douglas Watson | Director | Trussville, AL |
| SAMUEL LYNCH | Director | FRANKLIN, TN |
| SAMUEL LYNCH | Executive Officer | FRANKLIN, TN |
| Charles Federico | Director | Toronto, A6 |
| Steven Hirsch | Executive Officer | Houston, TX |
| Larry Papasan | Director | Atlanta, GA |
| Larry Bullock | Executive Officer | Franklin, TN |
| Russ Pagano | Executive Officer | Franklin, TN |
| Thorkil Christensen | Director | Franklin, TN |
| Earl Douglas | Executive Officer | FRANKLIN, TN |
| Gary Friedlaender | Director | Franklin, TN |
Other filings by this issuer (1)
More